Mostrando 486,101 - 486,120 Resultados de 487,202 Para Buscar '"free will"', tiempo de consulta: 2.47s Limitar resultados
  1. 486101
    “…The overall survival OS and progression-free survival PFS were used as endpoints to assess the long-term response to immunotherapy. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  2. 486102
    “…Patients with NSCLC harboring acquired T790M mutation treated with osimertinib had the best objective response rate (ORR) (52.6%, 25.0%, and 32.0%, p = 0.044), disease control rate (DCR) (79.3%, 41.7%, and 68.0%, p = 0.011), and progression-free survival (PFS, median PFS, 12.6, 3.1, 10.4 months, p = 0.001) among the three groups (positive, negative, and unknown T790M, respectively). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  3. 486103
    “…Those who developed dementia were older (mean [SD] age, 81.0 [5.2] years vs 79.1 [6.0] years), had a lower level of physical activity (median [IQR] activity, 1.0 [0-2.5] h/week vs 1.8 [0.2-3.8] h/week), and were more likely to be APOE ε4 carriers than those who were dementia-free (33 of 88 [37.5%] vs 56 of 283 [19.8%]). Compared with participants who remained cognitively intact, in those with incident MCI, BMI tended to decline earlier and faster. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  4. 486104
    “…METHODS: Two faculty-led, CME-accredited, web-based educational activities on T2D and obesity, touchIN CONVERSATION and touch MultiDisciplinary Team, were developed and made available on a free-to-access medical education website. Each activity comprised 3 videos lasting 10 to 15 minutes, which addressed learning objectives developed based on a review of published literature and faculty feedback. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  5. 486105
    “…The ORR in the dose-expansion group (6.0 mg/kg QW) was 48.0% (12/25, 95% CI, 27.8%–68.7%), the median progression-free survival was 5.2 months (95%CI, 3.6–5.5), and the median overall survival was 20.2 months (95%CI, 12.1-not reached). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  6. 486106
  7. 486107
    “…Further blood analysis revealed PTH 1176 pg/mL (14-64 pg/mL), TSH 2.69 uU/mL (0.35-4.94 uU/mL), free T4 1.12 ng/dL (0.60-1.89 ng/dL), vitamin D, 25-Hydroxy 24 ng/mL (30-80 ng/mL), serum calcium 12.6 mg/dl (8.9-10.4 mg/dL), ionized calcium 1.65 mmol/L (1.14-1.33 mmol/L), phosphorus 1.9 mg/dl (2.4-4.8 mg/dl), magnesium 1.0 mg/dl (1.8-3.0 mg/dL). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  8. 486108
    “…We also performed an OGTT with 75g of glucose for 180 min and observed a decrease in the area under the curve of insulin (-33.2%), triglycerides (-40.7%), and free fatty acids (-34%). DEXA scan showed a reduction in total body fat of 16%. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  9. 486109
    “…We evaluated the effects of diabetes on 1) overall survival (OS) and 2) the interval from initiation of first-line metastatic therapy to initiation of a second-line regimen due to documented progression of disease (a surrogate measure of progression-free survival). The impact of glycemic control on OS and duration of first-line therapy was also assessed. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  10. 486110
    “…METHODS: Weight (BW), height, BMI%, body fat% (BF%), daily insulin requirement, CGM data, HbA1c, and total and HMW adiponectin were measured in 24 young children (15 females, 9 males; age 6-11 years) with T1D. BF% and fat-free-mass (FFM) was measured by bioelectrical impedance. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  11. 486111
    “…Other pituitary hormones showed normal TSH 0.634 uIU/ml (0.35-4.9) with low free T4 0.64 (0.7-1.48), IGF-1 107 ng/mL (74-196), prolactin 10.92 mcg/mL (3.46-19.4), morning cortisol 8.9 mcg/dL (3.7-19.4). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  12. 486112
    “…Evaluation for secondary causes of hypotension were all negative [Cortisol of 19 ug/dL (n=5.3-22.5); ACTH 20 pg/mL (n=0-47); TSH 2.36 uIU/mL (n=0.358 -3.74); Free T4 0.97 ng/dL (n=0.76-1.46); B12 480 pg/mL (n=193-986); Hba1c 4.9%; 25 OH Vitamin D 24.3 ng/mL; tryptase 3.7 mcg/L (n= <11); Sed rate 4 mm/HR (n=0-20). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  13. 486113
    “…Workup for Cushing's revealed multiple normal midnight salivary cortisol levels and mild intermittent elevation of 24-hour urinary free cortisol levels. CT scan of the adrenals was negative for a mass. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  14. 486114
    “…Hepatic lipid derives from re-esterification of free fatty acids (FFA) from adipose tissue lipolysis and dietary sources, as well as de novo lipogenesis. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  15. 486115
    “…Additionally, the ratio mREE vs fat-free-mass (FFM) was calculated. RESULTS: We included 292 patients, of which 218 (75%) patients had multifactorial obesity and 74 (25%) had an underlying medical cause: non-syndromic and syndromic genetic (n= 29 and 28, respectively), hypothalamic (n= 10), and medication-induced (n= 7) obesity. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  16. 486116
    “…Computed tomography showed a20. 0×13.1×21.1 cm septate cystic and/or necrotic lesion arising from the left retroperitoneum versus adrenal gland, displacing the kidney anteromedially. Plasma free metanephrine was 3.38 nM (0-0.49) normetanephrine 3.47 nM (0-0.89),urine metanephrine 2605 mcg/day (36-229), urine normetanephrine 1215 mcg/day (95-650). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  17. 486117
    por Dsilva, Prajna, Majumdar, Sachin
    Publicado 2022
    “…Labs were initially sent to evaluate for an adrenal incidentaloma: A random morning (8 AM) cortisol was <0.5 mcg/dL (6-18 mcg/dL), plasma ACTH was 6pg/ml (7.2-63.3 pg/mL), 24 hour free urinary cortisol: < 1mcg/24 hours (2500 ml/ 24hr urine, urine creatinine 1.66g/24 hours). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  18. 486118
    por Goyal, Varunika
    Publicado 2022
    “…No difference was observed in the lipid profile (e.g., total cholesterol, triglycerides, phospholipids and free fatty acids) of WT and MT1KO mice under CD, while HFD significantly increased the cholesterol (149.5 vs 225.2 mg/dL, P<0.05) and phospholipids (287.8 vs. 358.6 mg/dL P<0.05) levels in MT1KOs. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  19. 486119
    “…CS was confirmed (Baseline: ACTH 96 [7.2-63.3 pg/ml], serum cortisol 19.6 [4.8 - 19.5 mcg/dL]; LDSST: cortisol 18.5 [<1.8 mcg/dL], dexamethasone 547 [>200 ng/dL]; 24-hour Urine Free Cortisol: 191.60 [<45 mcg/d], 24-hour Cr 484 mg/day; LNSC: 436, 464 [29-101 ng/dL]; 8 mg ODST cortisol 7.2 mcg/dL). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
  20. 486120
    “…BACKGROUND: Osilodrostat, a potent oral inhibitor of 11β-hydroxylase, demonstrated efficacy in normalizing urinary free cortisol (UFC) in Cushing's disease (CD) patients; however, information describing its use in clinical practice is limited. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
Herramientas de búsqueda: RSS